Sort
15,273 grants matching “antimicrobial resistance”
Small molecules for perturbing iron homeostasis in bacterial biofilms
$734,987Mario Rivera · Louisiana State Univ A&M Col Baton Rouge · R01 · FY2024 · AI
Antibacterial inhibitors of RnpA
$734,704Paul M. Dunman · University Of Rochester · R01 · FY2021 · AI
Novel polymeric materials with improved durability in the oral environment: tailoring responses to host and bacterial enzymes with anti-proteolytic and ecology-based antimicrobial approaches.
$734,605Carmem S. Pfeifer · Oregon Health & Science University · R35 · FY2019 · DE
Cooperation and antagonism in polymicrobial infection
$734,208Daniel J Wozniak · Ohio State University · R01 · FY2025 · AI
Exploiting antibody catalysis for treating Cryptococcosis
$734,148Arturo Casadevall · Johns Hopkins University · R01 · FY2021 · AI
Personalized Antimicrobial Combinations to Combat Resistance
$734,122Vincent H Tam · University Of Houston · R01 · FY2020 · AI
Novel, Long-Term Percutaneous Access Device for Chronic Therapy
$733,964Bradley C Poff · Viaderm, Llc · R44 · FY2014 · HL
Molecular Imaging for Pulmonary Infections and Inflammation
$733,500Sanjay Jain · Johns Hopkins University · R01 · FY2016 · HL
Comparative resistomics of Gram-negative bacterial pathogens
$733,500Andrei L Osterman · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2023 · AI
Comparative resistomics of Gram-negative bacterial pathogens
$733,500Andrei L Osterman · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2025 · AI
Comparative resistomics of Gram-negative bacterial pathogens
$733,500Andrei L Osterman · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2024 · AI
Comparative resistomics of Gram-negative bacterial pathogens
$733,500Andrei L Osterman · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2022 · AI
Early life antibiotics, gut microbiome development, and risk of childhood obesity
$733,455Jeffrey Stephen Gerber · Children'S Hosp Of Philadelphia · R01 · FY2017 · AI
Development of a broad spectrum teixobactin-lipopeptide hybrid for the treatment of lung infections caused by pan-drug resistant âsuperbugsâ
$732,598Gauri G Rao · University Of Southern California · R01 · FY2024 · AI
Broad-spectrum Antifolates for Treatment of Drug Resistant Bacillus anthracis
$732,571William Barrow · Oklahoma State University Stillwater · R01 · FY2013 · AI
Project 2: Targeting Gram-positive Cell Envelope Assembly
$732,322Suzanne L. Walker · Harvard Medical School · U19 · FY2023 · AI
Optimizing phagocyte activity against antibiotic resistant pathogens
$731,785Victor Nizet · University Of Chicago · U54 · FY2012 · AI
Broad spectrum Tricyclics GyrB, ParE inhibitors for antibacterial applications
$731,729Kenneth Bartizal · Rbhs-New Jersey Medical School · U19 · FY2014 · AI
Validating establishment of functional safety in skin interface with deeply porous transcutaneous pylon for direct skeletal attachment of limb prostheses
$731,608Mark Pitkin · Poly-Orth International · R44 · FY2022 · AR
Integrated Platform for the Discovery of Antibacterial
$731,560Suzanne L. Walker · Harvard Medical School · U19 · FY2015 · AI
Integrated Platform for the Discovery of Antibacterial
$731,405Suzanne L. Walker · Harvard Medical School · U19 · FY2017 · AI
Mechanism of the Fluoroquinolone Resistance Acquisition in Enterobacteria
$731,182Evgeni Veniaminovic Sokurenko · University Of Washington · R01 · FY2022 · AI
Personalized Antimicrobial Combinations to Combat Resistance
$730,882Vincent H Tam · University Of Houston · R01 · FY2019 · AI
The impact of bacteriophage therapy on wound infection dynamics
$730,575Daniel J Wozniak · Ohio State University · R01 · FY2025 · AI
Development of Antibiotic Adjuvants for Gram-Negative Bacteria
$730,556Christian C Melander · University Of Notre Dame · R01 · FY2020 · AI